IRAK4-IN-4 |
Katalog-Nr.GC38799 |
IRAK4-IN-4 ist ein Inhibitor der Interleukin-1-Rezeptor-assoziierten Kinase 4 (IRAK4), extrahiert aus dem Patent CN107163044A, Verbindung 15, und hat einen IC50-Wert von 2,8 nM.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1850276-58-2
Sample solution is provided at 25 µL, 10mM.
IRAK4-IN-4 is an interleukin-1 receptor-associated kinase 4 (IRAK4) inhibitor extracted from patent CN107163044A, Compound15, has an IC50 of 2.8 nM. IRAK4-IN-4 also inhibits cyclic GMP-AMP synthase (cGAS) with an IC50 of 2.1 nM[1].
[1]. One class has the naphthalene second dione compounds and its derivative of protease modification activities. CN107163044A.
Average Rating: 5
(Based on Reviews and 18 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *